Marker Therapeutics Inc (MRKR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.58
• Market Cap: $20.06M
• EPS: $-1.17
• 52-Week High: $2.46
• 52-Week Low: $0.81

Market Sentiment

Marker Therapeutics Inc currently has a Bullish sentiment score of 0.22.

About Marker Therapeutics Inc

Marker Therapeutics Inc. is a clinical-stage immuno-oncology company dedicated to developing groundbreaking T-cell-based immunotherapies and peptide-based vaccines targeting hematologic malignancies and solid tumors. Leveraging innovative technologies to mobilize the body’s immune response against cancer, Marker Therapeutics is strategically positioned in a high-growth sector of oncology. Based in Houston, Texas, the company is focused on delivering transformative treatment solutions that aim...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Marker Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MRKR pay dividends?

Marker Therapeutics Inc (MRKR) does not currently pay a regular dividend.

What is MRKR's market cap?

Marker Therapeutics Inc (MRKR) has a market capitalization of $20.06M with a current stock price of $1.58.